Join
Live feed
·
INSIDERFilingvia Quantisnow
Opus Genetics Inc. logo

New insider Foundation Fighting Blindness Retinal Degeneration Fund claimed ownership of 2,564,752 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRD (Opus Genetics Inc.) and more on Quantisnow.